1-20 of 36
Kunle Odunsi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1983: Cancer exosomes immunosuppressive activity in the absence of contaminating soluble factors is multifactorial

Shin La Shu, Junko Matsuzaki, Cheryl Allen, Yunchen Yang, Edward Hurley, Kunle Odunsi, Yun Wu, Marc S. Ernstoff
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1983.
https://doi.org/10.1158/1538-7445.AM2019-1983
Published: 01 July 2019
View article titled, Abstract 1983: Cancer exosomes immunosuppressive activity in the absence of contaminating soluble factors is multifactorial
Journal Articles

Abstract 620: Tumor microenvironment heterogeneity is not identified across multiple histologically similar tumors from the same patient

Carl D. Morrison, Jeffrey Conroy, Sean Glenn, Blake Burgher, Sarabjot Pabla, Maochun Qin, Antonios Papanicolau-Sengos, Jon Andreas, Vincent Giamo, Mary Nesline, Shipra Gandhi, Manu Pandey, Nischala Ammannagari, Kunle Odunsi, Marc Ernstoff, Mark Gardner
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 620.
https://doi.org/10.1158/1538-7445.AM2017-620
Published: 01 July 2017
View article titled, Abstract 620: Tumor microenvironment heterogeneity is not identified across multiple histologically similar tumors from the same patient
Journal Articles

Abstract 956: Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model

Kristen Starbuck, Robert McGray, Samar Masoumi-Moghaddam, Ariel Francois, Kunle Odunsi, Emese Zsiros
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 956.
https://doi.org/10.1158/1538-7445.AM2017-956
Published: 01 July 2017
View article titled, Abstract 956: Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model
Journal Articles

Abstract 606: Targeting multiple immune checkpoints and their ligands using a humanized mouse model of ovarian cancer

Ruea-Yea Huang, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 606.
https://doi.org/10.1158/1538-7445.AM2017-606
Published: 01 July 2017
View article titled, Abstract 606: Targeting multiple immune checkpoints and their ligands using a humanized mouse model of ovarian cancer
Journal Articles

Abstract 4557: Tumor immune profiling identifies multiple unique therapeutic targets that improve vaccination + oncolytic virotherapy against metastatic ovarian cancer

AJ Robert Mcgray, Cheryl Eppolito, Anthony Miliotto, Raya Huang, Kelly Singel, Jonathan Pol, Kyle Stephenson, Brahm H. Segal, Brian Lichty, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4557.
https://doi.org/10.1158/1538-7445.AM2017-4557
Published: 01 July 2017
View article titled, Abstract 4557: Tumor immune profiling identifies multiple unique therapeutic targets that improve vaccination + oncolytic virotherapy against metastatic ovarian cancer
Journal Articles

Abstract 1623: Minute variation in murine ovarian cancer preclinical models significantly impact immunotherapy results obtained for clinical trial

AJ Robert Mcgray, Kristen Starbuck, Samar Masoumi-Moghaddam, Ariel Francois, Kunle Odunsi, Emese Zsiros
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1623.
https://doi.org/10.1158/1538-7445.AM2017-1623
Published: 01 July 2017
View article titled, Abstract 1623: Minute variation in murine ovarian cancer preclinical models significantly impact immunotherapy results obtained for clinical trial
Journal Articles

Abstract 947: CXCR4 in combination with immune check point inhibition in ovarian cancer mouse model demonstrates potential for novel therapeutic strategies

Kristen Starbuck, Robert McGray, Samar Masoumi-Moghaddam, Ariel Francois, Kunle Odunsi, Emese Zsiros
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 947.
https://doi.org/10.1158/1538-7445.AM2017-947
Published: 01 July 2017
View article titled, Abstract 947: CXCR4 in combination with immune check point inhibition in ovarian cancer mouse model demonstrates potential for novel therapeutic strategies
Journal Articles

Abstract LB-186: Sustained efficacy of immunotherapy for solid tumors with novel dual CD4/CD8 T cell receptor engineered synergistic combination of hematopoietic stem cells and T cells

Richard C. Koya, Thinle Chodon, Junko Matsuzaki, Takemasa Tsuji, Satoko Matsueda, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-186.
https://doi.org/10.1158/1538-7445.AM2017-LB-186
Published: 01 July 2017
View article titled, Abstract LB-186: Sustained efficacy of immunotherapy for solid tumors with novel dual CD4/CD8 T cell receptor engineered synergistic combination of hematopoietic stem cells and T cells
Journal Articles

Abstract 4754: Overexpression of TSH and ERBB2 (HER2) receptors is associated with sharply decreased survival in high grade serous ovarian cancer

Brandon-Luke L. Seagle, Monica Dandapani, Chen Hui Luo, Claire Hoppenot, Robert Samuelson, Kevin H. Eng, Kunle Odunsi, Shohreh Shahabi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4754.
https://doi.org/10.1158/1538-7445.AM2016-4754
Published: 15 July 2016
View article titled, Abstract 4754: Overexpression of TSH and ERBB2 (HER2) receptors is associated with sharply decreased survival in high grade serous ovarian cancer
Journal Articles

Abstract 4753: Ovarian cancer stem cell marker ALDH1A2 is a candidate biomarker for patient selection for intraperitoneal chemotherapy

Brandon-Luke L. Seagle, Monica Dandapani, Chen Hui Luo, Claire Hoppenot, Robert Samuelson, Kevin H. Eng, Kunle Odunsi, Shohreh Shahabi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4753.
https://doi.org/10.1158/1538-7445.AM2016-4753
Published: 15 July 2016
View article titled, Abstract 4753: Ovarian cancer stem cell marker ALDH1A2 is a candidate biomarker for patient selection for intraperitoneal chemotherapy
Journal Articles

Abstract 414: Prospective profiling of systemic and loco-regional alterations during intraperitoneal chemotherapy for ovarian cancer, results from GOG 271

Shannon Grabosch, Anda M. Vlad, Tianzhou Ma, Jyothi T. Mony, Mary Strange, Joan Brozick, Julia Thaller, George Tseng, Xin Huang, Kathleen Moore, Kunle Odunsi, Robert P. Edwards
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 414.
https://doi.org/10.1158/1538-7445.AM2015-414
Published: 01 August 2015
View article titled, Abstract 414: Prospective profiling of systemic and loco-regional alterations during intraperitoneal chemotherapy for ovarian cancer, results from GOG 271
Journal Articles

Abstract 1991: FOXM1 expression in epithelial ovarian cancer coincides with gene amplification and functional loss of p53 and Rb and drives G2-M progression and target gene expression

Carter J. Barger, Wa Zhang, Kunle Odunsi, Adam R. Karpf
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1991.
https://doi.org/10.1158/1538-7445.AM2015-1991
Published: 01 August 2015
View article titled, Abstract 1991: FOXM1 expression in epithelial ovarian cancer coincides with gene amplification and functional loss of p53 and Rb and drives G2-M progression and target gene expression
Journal Articles

Abstract 4442: TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizing agents in monoclonal cells and comparison of clinical outcomes from The Cancer Genome Atlas data

Brandon-Luke L. Seagle, Gerda Hofstteter, Chia-Ping Yang, Kevin Eng, Oluwatosin Odunsi-Akanji, Kunle Odunsi, Shohreh Shahabi
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4442.
https://doi.org/10.1158/1538-7445.AM2015-4442
Published: 01 August 2015
View article titled, Abstract 4442: TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizing agents in monoclonal cells and comparison of clinical outcomes from The Cancer Genome Atlas data
Journal Articles

Abstract 4075: LAG3 and PD1 co-inhibitory molecules directly interact to limit CD8+ T cell signaling

Ruea-Yea Huang, Cheryl Eppolito, Ahmed Fadiel, Adel Hamza, Shashikant Lele, Junko Mastuzaki, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4075.
https://doi.org/10.1158/1538-7445.AM2014-4075
Published: 01 October 2014
View article titled, Abstract 4075: LAG3 and PD1 co-inhibitory molecules directly interact to limit CD8+ T cell signaling
Journal Articles

Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

Bridget Charbonneau, Matthew S. Block, William R. Bamlet, Robert A. Vierkant, Kimberly R. Kalli, Zachary Fogarty, David N. Rider, Thomas A. Sellers, Shelley S. Tworoger, Elizabeth Poole, Harvey A. Risch, Helga B. Salvesen, Lambertus A. Kiemeney, Laura Baglietto, Graham G. Giles, Gianluca Severi, Britton Trabert, Nicolas Wentzensen, Georgia Chenevix-Trench, for AOCS/ACS group, Alice S. Whittemore, Weiva Sieh, Jenny Chang-Claude, Elisa V. Bandera, Irene Orlow, Kathryn Terry, Marc T. Goodman, Pamela J. Thompson, Linda S. Cook, Mary Anne Rossing, Roberta B. Ness, Steven A. Narod, Jolanta Kupryjanczyk, Karen Lu, Ralf Butzow, Thilo Dörk, Tanja Pejovic, Ian Campbell, Nhu D. Le, Clareann H. Bunker, Natalia Bogdanova, Ingo B. Runnebaum, Diana Eccles, James Paul, Anna H. Wu, Simon A. Gayther, Estrid Hogdall, Florian Heitz, Stanley B. Kaye, Beth Y. Karlan, Hoda Anton-Culver, Jacek Gronwald, Claus K. Hogdall, Diether Lambrechts, Peter A. Fasching, Usha Menon, Joellen Schildkraut, Celeste Leigh Pearce, Douglas A. Levine, Susanne Kruger Kjaer, Daniel Cramer, James M. Flanagan, Catherine M. Phelan, Robert Brown, Leon F.A.G. Massuger, Honglin Song, Jennifer A. Doherty, Camilla Krakstad, Dong Liang, Kunle Odunsi, Andrew Berchuck, Allan Jensen, Jan Lubiński, Heli Nevanlinna, Yukie T. Bean, Galina Lurie, Argyrios Ziogas, Christine Walsh, Evelyn Despierre, Louise Brinton, Alexander Hein, Anja Rudolph, Agnieszka Dansonka-Mieszkowska, Sara H. Olson, Philipp Harter, Jonathan Tyrer, Allison F. Vitonis, Angela Brooks-Wilson, Katja K. Aben, Malcolm C. Pike, Susan J. Ramus, Elisabeth Wik, Cezary Cybulski, Jie Lin, Lara Sucheston, Robert Edwards, Valerie McGuire, Jenny Lester, Andreas du Bois, Lene Lundvall, Shan Wang-Gohrke, Lukasz M. Szafron, Sandrina Lambrechts, Hannah Yang, Matthias W. Beckmann, Liisa M. Pelttari, Anne M. Van Altena, David van den Berg, Mari K. Halle, Aleksandra Gentry-Maharaj, Ira Schwaab, Urmila Chandran, Janusz Menkiszak, Arif B. Ekici, Lynne R. Wilkens, Arto Leminen, Francesmary Modugno, Grace Friel, Joseph H. Rothstein, Ignace Vergote, Montserrat Garcia-Closas, Michelle A.T. Hildebrandt, Piotr Sobiczewski, Linda E. Kelemen, Paul D.P. Pharoah, Kirsten Moysich, Keith L. Knutson, Julie M. Cunningham, Brooke L. Fridley, Ellen L. Goode
Journal: Cancer Research
Cancer Res (2014) 74 (3): 852–861.
https://doi.org/10.1158/0008-5472.CAN-13-1051
Published: 02 February 2014
View article titled, Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with <em>IL1A</em> and <em>TNFSF10</em>
Open the PDF for Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with <em>IL1A</em> and <em>TNFSF10</em> in another window
Includes: Supplementary data
Journal Articles

Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus.

Michelle E. Amsler, Kristina A. Chmiel, Olesya Yaremko, Clare Carroll, Jingjing Yin, Terry Mashtare, Anthony Miliotto, Rachel Brightwell, Kunle Odunsi, Alice C. Ceacareanu
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-18.
https://doi.org/10.1158/1538-7445.AM2013-LB-18
Published: 15 April 2013
View article titled, Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus.
Journal Articles

Abstract 4844: Polymorphisms in regulatory T cell related genes and ovarian cancer survival.

Bridget Charbonneau, Keith Knutson, Robert A. Vierkant, Julie M. Cunningham, Zachary C. Fogarty, Kimberly R. Kalli, Matthew J. Maurer, Ann L. Oberg, Brooke L. Fridley, Claudia C. Preston, Paul D.P. Pharoah, Susan J. Ramus, Catherine M. Phelan, Kunle Odunsi, Kirsten Moysich, Ellen L. Goode
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4844.
https://doi.org/10.1158/1538-7445.AM2013-4844
Published: 15 April 2013
View article titled, Abstract 4844: Polymorphisms in regulatory T cell related genes and ovarian cancer survival.
Journal Articles

CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity

Nassima Redjimi, Caroline Raffin, Isabelle Raimbaud, Pascale Pignon, Junko Matsuzaki, Kunle Odunsi, Danila Valmori, Maha Ayyoub
Journal: Cancer Research
Cancer Res (2012) 72 (17): 4351–4360.
https://doi.org/10.1158/0008-5472.CAN-12-0579
Published: 30 August 2012
View article titled, CXCR3<sup>+</sup> T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Open the PDF for CXCR3<sup>+</sup> T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract 1659: Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer

Jie Shen, Dan Wang, Steven Gregory, Leo Medico, Qiang Hu, Shashikant Lele, Kunle Odunsi, Christine Ambrosone, Song Liu, Hua Zhao
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1659.
https://doi.org/10.1158/1538-7445.AM2012-1659
Published: 15 April 2012
View article titled, Abstract 1659: Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer
Journal Articles

Abstract 5398: Direct interaction of inhibitory molecules LAG-3 and PD-1 in murine CD8+ T cell signaling

Ruea-Yea Huang, Cheryl Eppolito, Junko Matsuzaki, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5398.
https://doi.org/10.1158/1538-7445.AM2012-5398
Published: 15 April 2012
View article titled, Abstract 5398: Direct interaction of inhibitory molecules LAG-3 and PD-1 in murine CD8+ T cell signaling